Taking into account the standard deviation of the price estimate, the stock could hit a price target of $54 on the low end and $95 on the high end, according to the report.
AmSurg has a market cap of $3.94 billion.
More articles on transactions and valuation issues:
AmSurg shares increase nearly 15%: 4 key points
MFC posts quarterly earnings
Surgery Partners files for IPO: 5 things to know
